-
2024 CSCO Guidelines Conference | Prof. Jun Ma: The Chinese Society of Clinical Oncology (CSCO) Guidelines for Malignant Hematologic Diseases Promote Standardized Diagnosis and Treatment in China and Improve Clinical Outcomes
The “2024 Chinese Society of Clinical Oncology (CSCO) Guidelines for Malignant Hematologic Diseases” are set to be released, updating the latest treatment strategies and methods for malignant hematologic diseases. This is a significant event for the hematology field in China. “Oncology Frontier” conducted an exclusive interview with Professor Jun Ma from the Harbin Institute of…
-
2024 EBMT Review | Professor Jun Ma:CARTITUDE-4 Study—Comparison of Efficacy between Cilta-cel and Standard Treatments in Patients with Relapsed or Refractory Multiple Myeloma
From April 14 to 17, 2024, the 50th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting was grandly held in Glasgow, UK, a city renowned for its historical significance. This year marks the 50th anniversary of EBMT, and the event gathered leading figures in the field of hematopoietic stem cell transplantation and over…
-
2024 EBMT Review | Professor Jun Ma:Development Study of Disease-Specific Composite Endpoints for CAR-T Cell Therapy in Large B-cell Lymphoma and Multiple Myeloma
From April 14 to 17, 2024, the 50th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting was grandly held in Glasgow, UK, a city renowned for its historical significance. This year marks the 50th anniversary of EBMT, and the event gathered leading figures in the field of hematopoietic stem cell transplantation and over…
-
Guidelines Consensus | Key Insights from the “Expert Consensus on Prevention and Treatment of Chronic Hepatitis B in Children” in China
With the widespread implementation of standard immunization programs and mother-to-child transmission prevention measures, the incidence of new HBV infections among children in China has significantly declined. However, due to the large base of hepatitis B patients and regional developmental disparities, the number of new and existing cases of HBV infections among children remains high.
-
Insights from a Study by Professor Yunsong Yu’s Team at ESCMID Global 2024
Carbapenem-resistant Enterobacteriaceae (CRE) has emerged as a significant global public health threat. In recent years, there has been increasing attention on ertapenem monotherapy-resistant CRE strains, making it a hot topic in the field. At the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024), a study (abstract number: P1469) by Professor Yunsong…
-
Potential Threat of Newly Identified ST20 Clone to Enzyme Inhibitor Combination Therapy: Findings from ESCMID Global 2024
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a significant challenge in nosocomial infections, with its resistance escalating, drawing global attention. At the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024), a study by Professor Yunsong Yu’s team from the Affiliated Hospital of Zhejiang University School of Medicine presented the latest findings…
-
Professor Guosheng Ren: Highlighting the French-Chinese Breast Cancer Forum, New Technologies Lead Developments in Breast-Conserving Surgery | 2024 SFBCS
In the vibrant spring of April in Chongqing, from April 19 to April 20, 2024, the “11th Sino-French (International) Advanced Breast Cancer Forum (SFBCS)” was held, co-hosted by several prestigious institutions including the Chinese Anti-Cancer Association’s Breast Cancer Committee, the Breast Surgery Expert Group of the Chinese Medical Doctor Association, the Oncology Clinical Research Management…
-
Professor Yongsheng Wang: Precision Decision-Making in Sentinel Lymph Node Biopsy—Selecting the Right Patient Population, Diagnosis, and Clinical Management | 2024 SFBCS
The 11th Sino-French (International) Advanced Breast Cancer Forum (SFBCS) was held in Chongqing on April 19-20, 2024. Experts from around the world shared their knowledge on basic breast cancer research, pathology diagnosis, surgical procedures, and systemic treatment. In the surgical forefront segment, Professor Yongsheng Wang from Shandong Cancer Hospital presented on “Precision Decision-Making in Sentinel…
Connecting Medical Expertise through Media